DarioHealth Reports $5.2 Million Revenue for Q2 2026
DarioHealth reported second quarter 2026 revenue of $5.2 million, as the company continued its strategic exit from certain pharmaceutical-related businesses.
DarioHealth reported revenue of $5.2 million for the second quarter of 2026, a figure that reflects the company's strategic decision to discontinue certain pharmaceutical-related business lines.
The company's gross margin increased to 62%, up from 57% in the first quarter of 2026 and 55% in the second quarter of 2025. Management attributed this improvement to factors including changes in product mix and a reduction in sales of lower-margin products.
"We are pleased to see strong growth in our digital solutions and improved profitability," stated the company's CEO.
DarioHealth is continuing its focus on digital health solutions, aiming to enhance profitability by prioritizing higher-margin business activities.